amphetamine and ketanserin

amphetamine has been researched along with ketanserin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's2 (20.00)18.2507
2000's3 (30.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glennon, RA2
Andrews, PR; Craik, DJ; Martin, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Calleja, JM; Castro, ME; Fontenla, JA; G-Ferreiro, T; Loza-García, I; Osuna, J; Raviña, E; Rodríguez, J; Rosa, E; Sanz, F1
Johnson, RG; Rose, GM; Stevens, KE1
Biedka, I; Brus, R; Drosik, M; Kostrzewa, RM; Nowak, P; Szczerbak, G1
Ahmad, R; Egerton, A; Grasby, PM; Hirani, E1
Larrauri, JA; Levin, ED1

Reviews

1 review(s) available for amphetamine and ketanserin

ArticleYear
Central serotonin receptors as targets for drug research.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:1

    Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin

1987

Other Studies

9 other study(ies) available for amphetamine and ketanserin

ArticleYear
Functional group contributions to drug-receptor interactions.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship

1984
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
    Journal of medicinal chemistry, 2017, 04-13, Volume: 60, Issue:7

    Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin

2017
Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl)benzocycloalkanones as analogues of butyrophenone.
    Journal of medicinal chemistry, 1994, Aug-05, Volume: 37, Issue:16

    Topics: Amphetamine; Animals; Antipsychotic Agents; Aorta; Apomorphine; Butyrophenones; Computer Simulation; Corpus Striatum; Dopamine D2 Receptor Antagonists; Frontal Lobe; Haloperidol; Ketanserin; Male; Models, Molecular; Motor Activity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists

1994
5-Hydroxytryptamine2 receptors modulate auditory filtering in the rat.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:2

    Topics: Amphetamine; Amphetamines; Animals; Dose-Response Relationship, Drug; Evoked Potentials, Auditory; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin

1998
Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006, Volume: 57, Issue:4

    Topics: Amphetamine; Animals; Animals, Newborn; Disease Models, Animal; Dopamine; Ketanserin; Male; Microdialysis; Neostriatum; Neurotransmitter Agents; Parkinson Disease; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C

2006
Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
    Psychopharmacology, 2008, Volume: 200, Issue:4

    Topics: Amphetamine; Animals; Binding, Competitive; Carbon Radioisotopes; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Indoles; Ketanserin; Male; Positron-Emission Tomography; Protein Binding; Pyridines; Raclopride; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists

2008
PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.
    Psychopharmacology, 2010, Volume: 212, Issue:4

    Topics: Acoustic Stimulation; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Female; Histamine H1 Antagonists; Inhibition, Psychological; Ketanserin; Physical Stimulation; Pyrilamine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists

2010